Reliance school seeks deemed varsity status
The News Review:
- Reliance school seeks deemed varsity status
- Sequoia Capital invests Rs.1 billion in GVK Bio
- Xceed Molecular Launches Strategic Collaborator Program; Signs Center…
- ArteFill in Head to Head Investigator-Initiated Study to Test…
- Some companies are better prepared for regulation than others
- Research funding hits high at UC
Reliance school seeks deemed varsity status
Economic Times – Nov 27, 2007
Currently seven programmesconsisting of three months of class room training and nine months of ?onthe job? training are being run in engineering clinical researchmanufacturing quality management research and development medico-marketingand agriculture. Programmes onclinical data management business and finance management and health care arebeing designed. External diploma programmes which are open to non-companyapplicants include biopharmaceuticals manufacturing and clinical research. These are 42-week duration programmes aimed at making candidates employable inbiopharmaceutical industries or in contract researchorganisations. RSLS currentlyhas a mix of full time adjunct and visiting faculty adding up to a total numberof 50 teaching staff. While elaborating on its deemed university plans the RLSspokesperson said: ?It is imperative to obtain university status in orderto offer post graduate and doctoral programmes. About seven domains in lifesciences and related areas have been identified for higher education andresearch.
Sequoia Capital invests Rs.1 billion in GVK Bio
Andhra Cafe – Nov 27, 2007
With the strength of its management and leadership we believe that the company is on its way to become a dominant force in the life science industry’ said Sandeep Singhal managing director Sequoia Capital. GVK started operations here in 2001. According to the company it is the only Indian clinical research organisation that provides a service platform ranging from informatics medical chemistry and biology services in discovery research to clinical research and data management services on the development side and further to process research and custom synthesis. The company accelerates the drug discovery and development process of its customers through science and innovation. Currently the company employs 1300 people spread across facilities in Hyderabad Chennai and Gurgaon near Delhi. Sequoia Capital India a market leader in private equity and venture has invested in India in over 30 companies over the last six years. Sequoia Capital India manages four funds totalling $1.
Xceed Molecular Launches Strategic Collaborator Program; Signs Center…
Free with registration – PR Newswire – AccessMyLibrary.com – Nov 27, 2007
Specific terms were not disclosed. According to Xceed’s President and CE David Deems the Strategic Collaborator program is a mutually beneficial agreement with a high-profile institution or investigator designed to propel the partners’ clinical research while providing Xceed with additional real-world clinical-laboratory experience and access to critical research results. CPYRIGHT 2007 PR Newswire Association LLC.
ArteFill in Head to Head Investigator-Initiated Study to Test…
Free with registration – Business Wire – AccessMyLibrary.com – Nov 27, 2007
This 24 patient study will evaluate nasolabial fold or smile line wrinkle correction over a two year period. Smith MD President Therapeutics Clinical Research Assistant Clinical Professor of Dermatology University of California San Diego Division of Dermatology is conducting this “split-face” study whereby patients will receive ArteFill on one side of their face and will receive a temporary dermal filler either Restylane or Radiesse on the other. Every three months photographs will be taken to allow a blinded evaluation of the patients’ degree of wrinkle correction. Patients will also be asked to provide.
Some companies are better prepared for regulation than others
NutraIngredients-usa.com – Nov 27, 2007
The Adverse Event Reporting (AER) regulations also came in this year obliging supplement manufacturers packers and distributors to notify the Food & Drug Administration (FDA) of any serious adverse events reports. These new regulations are thought to have an impact on the industry as it tightens up manufacturing procedures whilst increased security checks may lead to increased prices. Those products with proven clinical research for their products will be at a significant advantage according to Business Insights. The new FDA unit relating to food safety may also potentially affect trade both internally and externally according to the report. Harmonizing the dietary supplements industry is apparently having a negative impact on small and medium-sized businesses with more confusion financial pressure and barriers to trade. Two-thirds of industry executives consulted for the analysis rated Asia-Pacific as the region that will provide the most growth potential for supplements manufacturers over the next five years. This is because of significant changes predicted in the economic and regulatory structures in this area specifically in Brazil Russia India and China.
Research funding hits high at UC
Bizjournals.com – Nov 27, 2007
"The majority of UC's research funding comes from the. "UC researchers were able to increase the university's total NIH funding by more than $6 million in 2007. "That says a lot about the quality of research happening here. " Several colleges saw significant increases in their total research funding for 2007: Allied Health Sciences at $1.
Written by admin on November 27th, 2007 with
no comments.
Read more articles on News.